Sleepiz wins Start Summiteer competition

Sleepiz

At the Start Summit held last week in St. Gallen, Sleepiz was crowned the Start Summiteer 2019. The start-up develops a solution helping more than 1 billion people with sleep disorders.  Last week the start summit in St. Gallen brought together 3000 players in the startup ecosystem – from students to startups, investors, corporates and […]

Scailyte raises CHF 2.75M in seed funding and gains Swisscom Ventures & Zürcher Kantonalbank as investors

Scailyte AG, a Swiss startup in the emerging and rapidly growing field of single-cell technologies, raised CHF 2.75M in seed funding and gained Swisscom Ventures as a strategic investor. Zürcher Kantonalbank also joined the financing round, alongside the existing shareholders, thus reaffirming their trust in the competence and vision of Scailyte’s team. Dominique Megret, Head […]

Artidis: Cancer diagnosis in less than 3 hours

Marija Plodinec, CEO of Artidis (Img: Technologiepark Basel) “Artidis is based on the oldest diagnostic test on earth: palpation,” says Marija Plodinec, CEO and co-founder of Artidis AG. “In a nutshell, we palpate tissue on a molecular level,“ she adds with a twinkle. That’s because instead of a physician’s hand, Artidis runs a fine, high-precision […]

Resistell Closes Seed Round to Develop Faster Antibiotic Tests

Press release: Resistell AG closes seed round Resistell AG has today closed an oversubscribed seed financing round. Lead Investor Occident Group AG, Hemex AG and six other private investors invested in the EPFL spin-off developing the world’s fastest phenotypic antibiotic susceptibility test. 700,000 people die each year due to drug resistant infections. Unless we can […]

Scailyte wins Start JLM competition

Scailyte develops artificial intelligence technology to enable precision medicine and early detection of complex diseases. The company has won the Start JLM competition recently and will explore and experience Jerusalem’s vibrant startup ecosystem in November. Start JLM gives entrepreneurs the opportunity to connect and benefit from interaction with prominent local tech leaders in Jerusalem in a 7-day immersive […]

LK-01 Granted Orphan Drug Designation by the U.S. FDA for Acute Myeloid Leukemia

BARCELONA, Spain – Leukos Biotech, a spin-off company founded by the Barcelona based Jose Carreras Leukaemia Research Institute and supported by VCF Inveready, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for LK-01, a product based on Apomorphine, for the treatment of Acute Myeloid Leukemia. Acute Myeloid Leukaemia (AML) is […]